Pedro Clavero

2.1k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Pedro Clavero is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Pedro Clavero has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Pedro Clavero's work include Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (7 papers) and Dementia and Cognitive Impairment Research (5 papers). Pedro Clavero is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (7 papers) and Dementia and Cognitive Impairment Research (5 papers). Pedro Clavero collaborates with scholars based in Spain, United Kingdom and Netherlands. Pedro Clavero's co-authors include Estefanía Toledo, Ana Sánchez‐Tainta, Miguel Ángel Martínez‐González, Elena H. Martínez‐Lapiscina, María Rodríguez‐Oroz, José Á. Obeso, Ramón Estruch, Jordi Salas‐Salvadó, Cinta Valls‐Pedret and Emilio Ros and has published in prestigious journals such as Brain, Journal of Neurology Neurosurgery & Psychiatry and Human Brain Mapping.

In The Last Decade

Pedro Clavero

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial

2013 472 citations Elena H. Martínez‐Lapiscina, Pedro Clavero et al. Journal of Neurology Neurosurgery & Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedro Clavero Spain	14	497	485	412	186	171	25	1.3k
Erin L. Boespflug United States	17	226 0.5×	238 0.5×	187 0.5×	116 0.6×	326 1.9×	28	1.1k
A. Grandinetti United States	12	220 0.4×	982 2.0×	115 0.3×	83 0.4×	277 1.6×	20	1.6k
Moeko Noguchi‐Shinohara Japan	21	446 0.9×	313 0.6×	50 0.1×	256 1.4×	94 0.5×	62	1.3k
Marjo H. Eskelinen Sweden	6	432 0.9×	54 0.1×	277 0.7×	188 1.0×	69 0.4×	8	1.0k
Lucia Kerti Germany	9	447 0.9×	49 0.1×	148 0.4×	107 0.6×	63 0.4×	13	1.0k
Mauricio O. Nava-Mesa Colombia	15	502 1.0×	148 0.3×	40 0.1×	96 0.5×	237 1.4×	27	1.3k
Tiffany Nash United States	12	204 0.4×	76 0.2×	109 0.3×	66 0.4×	87 0.5×	22	1.0k
Erica Cassani Italy	21	421 0.8×	1.1k 2.2×	38 0.1×	220 1.2×	175 1.0×	27	1.8k
Therese Rider United States	22	627 1.3×	97 0.2×	126 0.3×	203 1.1×	143 0.8×	39	1.7k
Ilona Joniec‐Maciejak Poland	23	180 0.4×	243 0.5×	94 0.2×	41 0.2×	282 1.6×	53	1.0k

Countries citing papers authored by Pedro Clavero

Since Specialization

Citations

This map shows the geographic impact of Pedro Clavero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Clavero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Clavero more than expected).

Fields of papers citing papers by Pedro Clavero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Clavero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Clavero. The network helps show where Pedro Clavero may publish in the future.

Co-authorship network of co-authors of Pedro Clavero

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Clavero. A scholar is included among the top collaborators of Pedro Clavero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Clavero. Pedro Clavero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abellanas, Miguel Angel, Esther Luquin, Pedro Clavero, et al.. (2025). Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson’s disease. Brain Behavior and Immunity. 128. 600–611. 1 indexed citations

Meles, Sanne K., Remco J. Renken, Gert-Jan de Vries, et al.. (2024). Subspace corrected relevance learning with application in neuroimaging. Artificial Intelligence in Medicine. 149. 102786–102786. 6 indexed citations

Erro, María Elena, Itziar Gastón, Pedro Clavero, et al.. (2024). Epidemiologic and clinical features of multisystem atrophy: a population-based study in Navarre, Spain. Journal of Neurology. 271(10). 6647–6654.

Abellanas, Miguel Angel, Ibón Tamayo, Amaia Vilas‐Zornoza, et al.. (2024). Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity. Journal of Neuroinflammation. 21(1). 92–92. 4 indexed citations

Abellanas, Miguel Angel, Esther Luquin, África Vales, et al.. (2022). Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's disease. Glia. 71(3). 571–587. 43 indexed citations

Clavero, Pedro, et al.. (2020). Espacios de Virchow-Robin mesencefálicos y parkinsonismo: caso clínico y revisión de la literatura. Neurología. 36(2). 171–173. 1 indexed citations

Abellanas, Miguel Angel, Marta Zamarbide, Esther Luquin, et al.. (2019). Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions. Journal of Neuroinflammation. 16(1). 233–233. 47 indexed citations

Abellanas, Miguel Angel, Pedro Clavero, Marie-Laure Thiolat, et al.. (2018). The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia. Neurobiology of Disease. 118. 64–75. 25 indexed citations

Gasca‐Salas, Carmen, Daniel García-Lorenzo, David García‐García, et al.. (2017). Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia. Brain Imaging and Behavior. 13(1). 180–188. 24 indexed citations

10.

Biehl, Michael, Sanne K. Meles, Remco J. Renken, et al.. (2016). Differentiating Early and Late Stage Parkinson’s Disease Patients from Healthy Controls. University of Groningen research database (University of Groningen / Centre for Information Technology). 3(6). 33–43. 1 indexed citations

11.

Araya-Castillo, Luís, et al.. (2016). Grupos estratégicos en sectores de educación vespertina de economía y negocios en Chile. Revista de Ciencias Sociales. 21(4).

12.

Rodríguez‐Oroz, María, Belén Gago, Pedro Clavero, et al.. (2015). The Relationship Between Atrophy and Hypometabolism: Is It Regionally Dependent in Dementias?. Current Neurology and Neuroscience Reports. 15(7). 44–44. 13 indexed citations

13.

Gonzalez, R. Reina, David García‐García, Pedro Clavero, et al.. (2014). Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process. Brain. 137(8). 2356–2367. 123 indexed citations

14.

Martínez‐Lapiscina, Elena H., Pedro Clavero, Estefanía Toledo, et al.. (2013). Virgin olive oil supplementation and long-term cognition: the Predimed-Navarra randomized, trial. The journal of nutrition health & aging. 17(6). 544–552. 191 indexed citations

15.

Ortega‐Cubero, Sara, Pedro Clavero, R. Reina Gonzalez, et al.. (2013). Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: Two-year' follow-up. Parkinsonism & Related Disorders. 19(5). 543–547. 20 indexed citations

16.

Martínez‐Lapiscina, Elena H., Pedro Clavero, Estefanía Toledo, et al.. (2013). Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. Journal of Neurology Neurosurgery & Psychiatry. 84(12). 1318–1325. 472 indexed citations breakdown →

17.

García‐García, David, Pedro Clavero, Carmen Gasca‐Salas, et al.. (2012). Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 39(11). 1767–1777. 96 indexed citations

18.

Gonzalez, R. Reina, Jon B. Toledo, Pedro Clavero, et al.. (2012). The impact of silent vascular brain burden in cognitive impairment in Parkinson’s disease. European Journal of Neurology. 19(8). 1100–1107. 30 indexed citations

19.

Rodríguez‐Oroz, María, José V. Sánchez‐Mut, Isabel Lamet, et al.. (2009). Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study. Movement Disorders. 24(10). 1437–1444. 79 indexed citations

20.

Urrestarazu, Elena, Jorge Iriarte, Manuel Alegre, et al.. (2008). Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Movement Disorders. 24(2). 254–260. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact